|
 Dr. Merrill Garnett
is the founder and CEO of Garnett McKeen Laboratory, Inc. Holding a D.D.S. from New York University,
and graduate study in chemistry and biochemistry, Dr. Garnett has had research laboratories at the Central Islip
State Hospital, Waldemar Medical Research Foundation, Northport Veterans' Administration Medical Center, and the
High Technology Incubator of
The State University of New York at Stony Brook.
Dr. Garnett's principle laboratory discoveries reveal the presence of corollary dynamics of the genetic code by
which specific DNA coded segments and cell membranes exchange ultra-low frequency sinusoidal electrical currents.
According to his theory, these pulsed currents are the basis of all physiological pulses and determine the polarization,
charge and folding of enzymes, nucleic acids and membrane phospholipids. The restoration of these charge transfer
pathways form the basis of several new methods of medicinal management.
Investigators at the University of Utah and Columbia University have collaborated in studies of his compound, DNA
Reductase. This is the first non-toxic chemotherapeutic agent, a liquid crystal complex of palladium and lipoic
acid. Other new drugs are also under development. Dr. Garnett has been issued three United States patents related
to the treatment of tumors and psoriasis.
The above Bio. & Research information can be found at
www.electrogenetics.com
Important Note To Health Care Professionals:
For more information containing Scientific Data, call AMARC Enterprises Inc. toll free at 800-960-6760
and they can send you a complete informational pack with the science included. They will cover the cost of the
informational materials that are usually shipped via UPS.
For an overview of Dr. Merrill Garnett's years of research as well as excerpts from his book "First Pulse"
click here: www.electrogenetics.com
The Inductive Phase State of Gene Polymer Pulsation Compensates for the Absence of Time, Energy, and Distance
Parameters of the Genetic Code Merrill Garnett.
The modern genetic code is a gene base sequence theory whose regulatory influence is implied from the feedback
experiments of bacterial genetics and modern mammalian genetics. Nevertheless, this intellectual framework has
failed to disclose the mechanisms of differentiation intrinsic to understanding cell development, aging, and cancer.
The weakness lies in the absence of dynamical parameters.
Since 1987 a few investigators have sought and observed other explanations at the DNA level. These reports describe
energy storage and retrieval in the unstacked gene base sequences, and DNA oscillations. From measurements with
Raman spectroscopy (Volkov & Kosevich), and from theoretical calculations (Bistolfi, also Prohofsky et al,
also Chou et al.) an electron dynamic second DNA code emerges. I have reported that measurements with impedance
spectroscopy and frequency domain analysis, confirm the oscillatory data. This concept allows the synthesis of
drugs designed to act on the exchange of energy at the DNA level. The drugs act as electro-chemical reagents, demonstrating
the catalytic addition of electrons to DNA. In so doing it becomes clear that a variety of protozoa and tumor cell
lines suffer membrane disruption from the 250 millivolt inward current.
In other parallel research, since 1988, workers at Columbia and Caltech have made abundant reports showing stacked
sequences of gene bases are able to transfer photo-activated electrons within DNA in the long axis. This is a strong
argument for gene to gene signaling or energy transfer.
It becomes necessary to integrate all these reactions into equivalent electronic circuitry as a cell function.
To this end the impedance plots were examined from the conventions of electro-chemistry. Since DNA manifests three
arcs in the upper right quadrant of the Nyquist plot, it is therefore a variable capacitor at negative voltages.
At positive voltages, when exposed to a corrosion driven cation pump, DNA and RNA manifest pseudo-inductance. It
is this pulsed inductive magnetic component which is capable of long range penetration of the heterogeneous biological
state, and which carries cell to cell integrative biopotential feedback. Fatty acid and phospholipid electron donors
are capacitative. Synthetic chemotherapy agents which transfer current to DNA and RNA share with the gene polymers
a common ultra-low frequency - demonstrating resonance. These data support models for a cellular circuit directly
analogous to oscillator or tank circuits.
These oscillator or pulsed circuits use a frequency at .285 Hertz - about 17 beats/minute. It is this frequency
which is believed to be responsible for the apoptosis effects of POLY-MVA. High flux oscillating electron flow
produces clonal selection allowing arrival of only the competent electron transfer cell systems, and therefore
presents a dynamical model for the design of anti-cancer drugs. Two catalytic chemotherapy agents have been synthesized:
the liquid crystal polymer of palladium and lipoic acid acts as a DNA reductase POLY-MVA, and its new derivative
act as an RNA reductase. These have different anti-tumor spectra and receptor mechanisms. The RNA reductase produces
dense heterochromatin which is traditionally a gene suppressive action. We are trying to reproduce DNA to RNA hybridization
in vitro to account for the heterochromatic mechanics of gene suppression by RNA reductase.
In summary, genetic control extends from cell to cell by long range pulsed magnetic induction according to the
Faraday-Maxwell-Heaviside law: curl B = 4 pi C, translated conceptually as - the net circulating magnetic field
around a wire or a long molecule carrying a current is equal to 4 pi times the current density.
|
